Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;39(8):1693-1712.
doi: 10.1007/s10815-022-02570-5. Epub 2022 Jul 23.

A synopsis of global frontiers in fertility preservation

Affiliations
Review

A synopsis of global frontiers in fertility preservation

L M Ataman et al. J Assist Reprod Genet. 2022 Aug.

Erratum in

  • Correction to: A synopsis of global frontiers in fertility preservation.
    Ataman LM, Laronda MM, Gowett M, Trotter K, Anvari H, Fei F, Ingram A, Minette M, Suebthawinkul C, Taghvaei Z, Torres-Vélez M, Velez K, Adiga SK, Anazodo A, Appiah L, Bourlon MT, Daniels N, Dolmans MM, Finlayson C, Gilchrist RB, Gomez-Lobo V, Greenblatt E, Halpern JA, Hutt K, Johnson EK, Kawamura K, Khrouf M, Kimelman D, Kristensen S, Mitchell RT, Moravek MB, Nahata L, Orwig KE, Pavone ME, Pépin D, Pesce R, Quinn GP, Rosen MP, Rowell E, Smith K, Venter C, Whiteside S, Xiao S, Zelinski M, Goldman KN, Woodruff TK, Duncan FE. Ataman LM, et al. J Assist Reprod Genet. 2022 Aug;39(8):1713-1714. doi: 10.1007/s10815-022-02586-x. Epub 2022 Aug 3. J Assist Reprod Genet. 2022. PMID: 35920992 Free PMC article. No abstract available.

Abstract

Since 2007, the Oncofertility Consortium Annual Conference has brought together a diverse network of individuals from a wide range of backgrounds and professional levels to disseminate emerging basic and clinical research findings in fertility preservation. This network also developed enduring educational materials to accelerate the pace and quality of field-wide scientific communication. Between 2007 and 2019, the Oncofertility Consortium Annual Conference was held as an in-person event in Chicago, IL. The conference attracted approximately 250 attendees each year representing 20 countries around the world. In 2020, however, the COVID-19 pandemic disrupted this paradigm and precluded an in-person meeting. Nevertheless, there remained an undeniable demand for the oncofertility community to convene. To maintain the momentum of the field, the Oncofertility Consortium hosted a day-long virtual meeting on March 5, 2021, with the theme of "Oncofertility Around the Globe" to highlight the diversity of clinical care and translational research that is ongoing around the world in this discipline. This virtual meeting was hosted using the vFairs ® conference platform and allowed over 700 people to participate, many of whom were first-time conference attendees. The agenda featured concurrent sessions from presenters in six continents which provided attendees a complete overview of the field and furthered our mission to create a global community of oncofertility practice. This paper provides a synopsis of talks delivered at this event and highlights the new advances and frontiers in the fields of oncofertility and fertility preservation around the globe from clinical practice and patient-centered efforts to translational research.

Keywords: Cancer; Fertility preservation; Oncofertility.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Graphs illustrating the growth of the conference in terms of A number of participants and B numbers of countries represented. The number of countries represented is based on self-reported registration information. The change to a virtual format increased overall participation and accessibility. (Note there was no conference in 2020 due to the COVID-19 pandemic.)
Fig. 2
Fig. 2
A map of countries represented by attendees at the 2021 Oncofertility Around the Globe meeting
Fig. 3
Fig. 3
Graphs illustrating the self-reported demographic data from conference attendees from 2012–2021 including A race and B ethnicity/origin. All data was self-reported and collected at the time of conference registration. Race and ethnicity were not required fields on the data registration form. Percentages are calculated based on individuals who completed these fields on their registrations. Calculations were based on the following number of responses per year: 2012: 97; 2013: 112; 2014: 151; 2015: 186; 2016: 219; 2017: 204; 2018: 200; 2019: 231; 2021: 663

Similar articles

Cited by

References

    1. Woodruff TK. Oncofertility: a grand collaboration between reproductive medicine and oncology. Reproduction. 2015;150(3):S1–10. doi: 10.1530/REP-15-0163. - DOI - PMC - PubMed
    1. Armstrong GT, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med. 2016;374(9):833–842. doi: 10.1056/NEJMoa1510795. - DOI - PMC - PubMed
    1. Armstrong GT, Yasui Y, Robison LL. Reduction in late mortality after childhood cancer. N Engl J Med. 2016;375(3):290–292. - PubMed
    1. Weir HK, et al. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer. 2015;121(11):1827–1837. doi: 10.1002/cncr.29258. - DOI - PMC - PubMed
    1. Cox CL, et al. Noncancer-related mortality risks in adult survivors of pediatric malignancies: the childhood cancer survivor study. J Cancer Surviv. 2014;8(3):460–471. doi: 10.1007/s11764-014-0353-7. - DOI - PMC - PubMed